IHS Chemical Week

Wacker acquires biologics firm in Germany

12:52 PM MST | November 12, 2013

Wacker Biotech, a subsidiary of Wacker Chemie, today announced plans to acquire a production site for bioengineered pharmaceutical proteins (biologics), including the associated business, from BioNet Ventures. The two companies today signed the purchase agreement, which covers Wacker's acquisition of Scil Proteins Production, including the patent portfolio, at the Scil site at Halle, Germany. The transaction is expected to close early next year. Wacker will continue with existing customer partnerships, which Scil Proteins Production already has, and will retain...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 

Username:
Password:

Forgot your user ID or password? Click here to have it sent to you.

 

 

If you are not yet a subscriber and would like to access the turnkey information found only in Chemweek’s Business Daily, subscribe now and you’ll get the most important news of the chemical industry delivered directly to your inbox—every day.

Sign up for a FREE 15-day trial of IHS Chemical Week Business Daily













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa